[EXPOSED] This diabetes drug coverup could MAKE YOU SICK
They KNEW.
They KNEW they had a BAD drug with a BIG problem.
They KNEW this diabetes medication… unleashed with GREAT fanfare and to MASSIVE sales… was hiding a TERRIFYING side effect…
And they KNEW it was getting WORSE.
The company behind the drug KNEW all of this, according to a new report…
And had a chance to ACT EARLY and TELL US ALL.
Someone within the company even URGED them to do exactly that.
But in a battle of patients versus profits… do you even have to GUESS which they picked?
Turns out… and there’s no surprise here… the drugmaker spent YEARS trying to cover up a major problem with the drug.
So today, allow me to give you the inside scoop.
Here’s how the drug industry REALLY operates when they THINK no one’s watching.
And more importantly, allow me to share some advice on the best way to protect yourself… so you’re not a victim of the NEXT big scandal.
You REALLY want to avoid this diabetes drug
This diabetes drug is one I’ve warned you about before — canagliflozin, a.k.a. Johnson & Johnson’s Invokana.
But now, I’m not the ONLY one who’s spotted some funny business with it!
For its STUNNING new report, the Reuters news agency INTERVIEWED several former J&J employees… and REVIEWED company documents related to the drug’s development, rollout and safety from 2010 to 2014…
And it found that “J&J was repeatedly alerted to Invokana’s ketoacidosis risk and took no action.”
In fact, action was ONLY takenAFTER regulators INTERVENED…
FIVE YEARS LATER!
Reuters notes that ketoacidosis was behind about 4,000 of the 23,000 adverse event reports received by the FDA from 2013 to 2020.
Ketoacidosis is a dangerous buildup of acids in the blood – one that can be DEADLY if docs AREN’T looking for it and DON’T treat it fast.
Yet for as much as 5 YEARS, docs WEREN’T looking for it… because they WEREN’T TOLD it was a risk.
Now, there was ONE doctor on the drug’s safety team who did his job. He warned that the company should take swift action… alert the FDA and regulators in Europe to the problem… and “get out in front of this.”
The company DID NOT take swift action. It DID NOT alert regulators. And it DID NOT get out in front of it.
According to Reuters, they gave that doctor on the safety team a formal reprimand letter warning him to shut up or lose his job!
They didn’t have to FIRE him, as it turned out. He QUIT after that. (My respect to him.)
The guy who reprimanded him? He’s now a hotshot vice president… in charge PRODUCT SAFETY, for crying out loud… at a Chinese drug company.
Ya just can’t make this $#!^ up!
Now, of course, the first action here is to AVOID this drug like the plague that it is…
And I’d say the same for every med in its class, called SGLT2 inhibitors… which have been linked repeatedly to everything from genital infections to lower limb amputations .
You’d have to try REALLY hard to come up with a worse list of side effects!
But the second action is to be suspicious of ANY “latest and greatest” drug on the market.
They’re RUSHING OUT to make money FAST during their patent window – and companies will fight like heck to protect the drug during that period.
Stick to the tried-and-true instead – ideally stuff that’s been around so long there are no surprises anymore.
So, even when there ARE risks… you at least KNOW what they’ll be.
And to limit that, rely on natural therapies when they’re an option. If you have diabetes, talk to a doc about chromium… berberine… Gymnema sylvestre… and/or vanadium.
And here’s something that ISN’T optional when you have diabetes: Follow a low-carb diet.
